{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NF-\u03baB signaling", "ampelopsin", "breast cancer", "cancer stem cells", "medicinal plants", "mitochondrial respiration", "oxidative phosphorylation", "resistance"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34451892", "DateRevised": {"Year": "2021", "Month": "08", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "12"}], "Language": ["eng"], "ELocationID": ["794", "10.3390/ph14080794"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "14", "Issue": "8", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "12"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Ampelopsin Suppresses Stem Cell Properties Accompanied by Attenuation of Oxidative Phosphorylation in Chemo- and Radio-Resistant MDA-MB-231 Breast Cancer Cells.", "Abstract": {"AbstractText": ["Ampelopsin, also known as dihydromyricetin, is a commonly found flavonoid in medicinal plants. The cancer stem cell (CSC) population is a promising target for triple-negative breast cancer (TNBC). In this study, flavonoid screening was performed in the established MDA-MB-231/IR cell line, which is enriched in CSCs. Ampelopsin suppressed the proliferation and colony formation of stem cell-rich MDA-MB-231/IR, while inducing their apoptosis. Importantly, ampelopsin displayed an inhibitory impact on the stemness features of MDA-MB-231/IR cells, demonstrated by decreases in mammosphere formation, the CD44<sup>+</sup>/CD24<sup>-/low</sup> population, aldehyde dehydrogenase activity, and the levels of stem cell markers (e.g., CD44, MRP1, \u03b2-catenin, and KLF4). Ampelopsin also suppressed the epithelial-mesenchymal transition, as evidenced by decreases in migration, invasion capacity, and mesenchymal markers, as well as an increase in the epithelial marker E-cadherin. Moreover, ampelopsin significantly impaired oxidative phosphorylation by reducing the oxygen consumption rate and adenosine triphosphate production in MDA-MB-231/IR cells. Notably, ampelopsin treatment significantly reduced the levels of the phosphorylated forms of I\u03baB\u03b1 and NF-\u03baB p65, as well as the levels of tumor necrosis factor (TNF)-\u03b1-stimulated phosphorylation of I\u03baB\u03b1 and NF-\u03baB p65. These results demonstrated that ampelopsin prevents the TNF-\u03b1/NF-\u03baB signaling axis in breast CSCs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea."}], "LastName": "Truong", "ForeName": "Vi Nguyen-Phuong", "Initials": "VN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea."}], "LastName": "Nguyen", "ForeName": "Yen Thi-Kim", "Initials": "YT"}, {"Identifier": ["0000-0002-0980-2005"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea."}, {"Identifier": [], "Affiliation": "Subtropical/Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea."}], "LastName": "Cho", "ForeName": "Somi-Kim", "Initials": "SK"}], "GrantList": [{"GrantID": "2020R1A2C1004349", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Yin L., Duan J.-J., Bian X.-W., Yu S.-C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:1\u201313. doi: 10.1186/s13058-020-01296-5.", "ArticleIdList": ["10.1186/s13058-020-01296-5", "PMC7285581", "32517735"]}, {"Citation": "Park S.Y., Choi J.H., Nam J.S. Targeting Cancer Stem Cells in Triple-Negative Breast Cancer. Cancers. 2019;11:965. doi: 10.3390/cancers11070965.", "ArticleIdList": ["10.3390/cancers11070965", "PMC6678244", "31324052"]}, {"Citation": "Butti R., Gunasekaran V.P., Kumar T.V., Banerjee P., Kundu G.C. Breast cancer stem cells: Biology and therapeutic implications. Int. J. Biochem. Cell Biol. 2019;107:38\u201352. doi: 10.1016/j.biocel.2018.12.001.", "ArticleIdList": ["10.1016/j.biocel.2018.12.001", "30529656"]}, {"Citation": "Yang L., Shi P., Zhao G., Xu J., Peng W., Zhang J., Zhang G., Wang X., Dong Z., Chen F. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Ther. 2020;5:1\u201335. doi: 10.1038/s41392-020-0110-5.", "ArticleIdList": ["10.1038/s41392-020-0110-5", "PMC7005297", "32296030"]}, {"Citation": "Koh S.Y., Moon J.Y., Unno T., Cho S.K. Baicalein suppresses stem cell-like characteristics in radio-and chemoresistant MDA-MB-231 human breast cancer cells through up-regulation of IFIT2. Nutrients. 2019;11:624. doi: 10.3390/nu11030624.", "ArticleIdList": ["10.3390/nu11030624", "PMC6471144", "30875792"]}, {"Citation": "Nguyen Y.T.-K., Moon J.Y., Ediriweera M.K., Cho S.K. Phenethyl isothiocyanate suppresses stemness in the chemo-and radio-resistant triple-negative breast cancer cell line MDA-MB-231/IR via downregulation of metadherin. Cancers. 2020;12:268. doi: 10.3390/cancers12020268.", "ArticleIdList": ["10.3390/cancers12020268", "PMC7072670", "31979093"]}, {"Citation": "Wang W., Nag S.A., Zhang R. Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy. Curr. Med. Chem. 2015;22:264\u2013289. doi: 10.2174/0929867321666141106124315.", "ArticleIdList": ["10.2174/0929867321666141106124315", "PMC6690202", "25386819"]}, {"Citation": "Rinkenbaugh A.L., Baldwin A.S. The NF-\u03baB Pathway and Cancer Stem Cells. Cells. 2016;5:16. doi: 10.3390/cells5020016.", "ArticleIdList": ["10.3390/cells5020016", "PMC4931665", "27058560"]}, {"Citation": "Giridharan S., Srinivasan M. Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation. J. Inflamm. Res. 2018;11:407\u2013419. doi: 10.2147/JIR.S140188.", "ArticleIdList": ["10.2147/JIR.S140188", "PMC6217131", "30464573"]}, {"Citation": "Wang L., Kang F., Li J., Zhang J., Shan B. Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. Cancer Cell Int. 2013;13:1\u20139. doi: 10.1186/1475-2867-13-14.", "ArticleIdList": ["10.1186/1475-2867-13-14", "PMC3586361", "23402310"]}, {"Citation": "Lu X., An H., Jin R., Zou M., Guo Y., Su P., Liu D., Shyr Y., Yarbrough W. PPM1A is a RelA phosphatase with tumor suppressor-like activity. Oncogene. 2014;33:2918\u20132927. doi: 10.1038/onc.2013.246.", "ArticleIdList": ["10.1038/onc.2013.246", "PMC3897569", "23812431"]}, {"Citation": "Christian F., Smith E.L., Carmody R.J. The Regulation of NF-\u03baB Subunits by Phosphorylation. Cells. 2016;5:12. doi: 10.3390/cells5010012.", "ArticleIdList": ["10.3390/cells5010012", "PMC4810097", "26999213"]}, {"Citation": "Merkhofer E.C., Cogswell P., Baldwin A.S. Her2 activates NF-\u03baB and induces invasion through the canonical pathway involving IKK\u03b1. Oncogene. 2010;29:1238\u20131248. doi: 10.1038/onc.2009.410.", "ArticleIdList": ["10.1038/onc.2009.410", "PMC2829103", "19946332"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Kalyanaraman B. Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. Redox. Biol. 2017;12:833\u2013842. doi: 10.1016/j.redox.2017.04.018.", "ArticleIdList": ["10.1016/j.redox.2017.04.018", "PMC5406543", "28448945"]}, {"Citation": "Snyder V., Reed-Newman T.C., Arnold L., Thomas S.M., Anant S. Cancer Stem Cell Metabolism and Potential Therapeutic Targets. Front. Oncol. 2018;8:203. doi: 10.3389/fonc.2018.00203.", "ArticleIdList": ["10.3389/fonc.2018.00203", "PMC5996058", "29922594"]}, {"Citation": "Valle S., Alcal\u00e1 S., Martin-Hijano L., Cabezas-S\u00e1inz P., Navarro D., Mu\u00f1oz E.R., Yuste L., Tiwary K., Walter K., Ruiz-Ca\u00f1as L. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Nat. Commun. 2020;11:1\u201319. doi: 10.1038/s41467-020-18954-z.", "ArticleIdList": ["10.1038/s41467-020-18954-z", "PMC7567808", "33067432"]}, {"Citation": "Liu G., Luo Q., Li H., Liu Q., Ju Y., Song G. Increased oxidative phosphorylation is required for stemness maintenance in liver cancer stem cells from hepatocellular carcinoma cell line HCCLM3 cells. Int. J. Mol. Sci. 2020;21:5276. doi: 10.3390/ijms21155276.", "ArticleIdList": ["10.3390/ijms21155276", "PMC7432880", "32722385"]}, {"Citation": "Mauro C., Leow S.C., Anso E., Rocha S., Thotakura A.K., Tornatore L., Moretti M., De Smaele E., Beg A.A., Tergaonkar V. NF-\u03baB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat. Cell Biol. 2011;13:1272\u20131279. doi: 10.1038/ncb2324.", "ArticleIdList": ["10.1038/ncb2324", "PMC3462316", "21968997"]}, {"Citation": "Sica V., Bravo-San Pedro J.M., Stoll G., Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. Int. J. Cancer. 2020;146:10\u201317. doi: 10.1002/ijc.32616.", "ArticleIdList": ["10.1002/ijc.32616", "31396957"]}, {"Citation": "Bassa L.M., Jacobs C., Gregory K., Henchey E., Ser-Dolansky J., Schneider S.S. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells. Phytomedicine. 2016;23:87\u201394. doi: 10.1016/j.phymed.2015.11.014.", "ArticleIdList": ["10.1016/j.phymed.2015.11.014", "26850689"]}, {"Citation": "Seo E.-J., Wiench B., Hamm R., Paulsen M., Zu Y., Fu Y., Efferth T. Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres. Phytomedicine. 2015;22:438\u2013443. doi: 10.1016/j.phymed.2015.01.012.", "ArticleIdList": ["10.1016/j.phymed.2015.01.012", "25925965"]}, {"Citation": "Wu C.-H., Hong B.-H., Ho C.-T., Yen G.-C. Targeting cancer stem cells in breast cancer: Potential anticancer properties of 6-shogaol and pterostilbene. J. Agric. Food Chem. 2015;63:2432\u20132441. doi: 10.1021/acs.jafc.5b00002.", "ArticleIdList": ["10.1021/acs.jafc.5b00002", "25686711"]}, {"Citation": "Vlashi E., Lagadec C., Vergnes L., Reue K., Frohnen P., Chan M., Alhiyari Y., Dratver M.B., Pajonk F. Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res. Treat. 2014;146:525\u2013534. doi: 10.1007/s10549-014-3051-2.", "ArticleIdList": ["10.1007/s10549-014-3051-2", "PMC4131557", "25007966"]}, {"Citation": "Ashraf M.A. Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature\u2019s Bounty. Biomed Res. Int. 2020;2020:8602879. doi: 10.1155/2020/8602879.", "ArticleIdList": ["10.1155/2020/8602879", "PMC7013350", "32076618"]}, {"Citation": "Kim S.-H., Hwang K.-A., Choi K.-C. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J. Nutr. Biochem. 2016;28:70\u201382. doi: 10.1016/j.jnutbio.2015.09.027.", "ArticleIdList": ["10.1016/j.jnutbio.2015.09.027", "26878784"]}, {"Citation": "Palit S., Kar S., Sharma G., Das P.K. Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1/JNK pathway. J. Cell. Physiol. 2015;230:1729\u20131739. doi: 10.1002/jcp.24818.", "ArticleIdList": ["10.1002/jcp.24818", "25204891"]}, {"Citation": "Knickle A., Fernando W., Greenshields A.L., Rupasinghe H.V., Hoskin D.W. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide. Food Chem. Toxicol. 2018;118:154\u2013167. doi: 10.1016/j.fct.2018.05.005.", "ArticleIdList": ["10.1016/j.fct.2018.05.005", "29742465"]}, {"Citation": "Zhao Z., Jin G., Ge Y., Guo Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology. 2019;27:1021\u20131036. doi: 10.1007/s10787-018-00556-3.", "ArticleIdList": ["10.1007/s10787-018-00556-3", "30941613"]}, {"Citation": "Huang L., Jin K., Lan H. Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase. Oncol. Lett. 2019;17:3842\u20133850. doi: 10.3892/ol.2019.10052.", "ArticleIdList": ["10.3892/ol.2019.10052", "PMC6425390", "30930986"]}, {"Citation": "Chien S.-Y., Wu Y.-C., Chung J.-G., Yang J.-S., Lu H.-F., Tsou M.-F., Wood W., Kuo S.-J., Chen D.-R. Quercetin-induced apoptosis acts through mitochondrial-and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum. Exp. Toxicol. 2009;28:493\u2013503. doi: 10.1177/0960327109107002.", "ArticleIdList": ["10.1177/0960327109107002", "19755441"]}, {"Citation": "Zhang Y., Que S., Yang X., Wang B., Qiao L., Zhao Y. Isolation and identification of metabolites from dihydromyricetin. Magn. Reson. Chem. 2007;45:909\u2013916. doi: 10.1002/mrc.2051.", "ArticleIdList": ["10.1002/mrc.2051", "17924358"]}, {"Citation": "Hyun T.K., Eom S.H., Yu C.Y., Roitsch T. Hovenia dulcis\u2014An Asian traditional herb. Planta Med. 2010;76:943\u2013949. doi: 10.1055/s-0030-1249776.", "ArticleIdList": ["10.1055/s-0030-1249776", "20379955"]}, {"Citation": "Liu D., Mao Y., Ding L., Zeng X.-A. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability. Trends Food Sci. Technol. 2019;91:586\u2013597. doi: 10.1016/j.tifs.2019.07.038.", "ArticleIdList": ["10.1016/j.tifs.2019.07.038", "PMC7127391", "32288229"]}, {"Citation": "Zhang J., Chen Y., Luo H., Sun L., Xu M., Yu J., Zhou Q., Meng G., Yang S. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Front. Pharmacol. 2018;9:1204. doi: 10.3389/fphar.2018.01204.", "ArticleIdList": ["10.3389/fphar.2018.01204", "PMC6209623", "30410442"]}, {"Citation": "Xu Y., Wang S., Chan H.F., Lu H., Lin Z., He C., Chen M. Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin. Sci. Rep. 2017;7:46060. doi: 10.1038/srep46060.", "ArticleIdList": ["10.1038/srep46060", "PMC5402300", "28436480"]}, {"Citation": "Tong H., Zhang X., Tan L., Jin R., Huang S., Li X. Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases. Eur. J. Pharmacol. 2020;870:172888. doi: 10.1016/j.ejphar.2019.172888.", "ArticleIdList": ["10.1016/j.ejphar.2019.172888", "31866404"]}, {"Citation": "Yu S.W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., Dawson V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. USA. 2006;103:18314\u201318319. doi: 10.1073/pnas.0606528103.", "ArticleIdList": ["10.1073/pnas.0606528103", "PMC1838748", "17116881"]}, {"Citation": "Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976\u20133985.", "ArticleIdList": ["8358726"]}, {"Citation": "Lundholm L., H\u00e5\u00e5g P., Zong D., Juntti T., M\u00f6rk B., Lewensohn R., Viktorsson K. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis. 2013;4:e478. doi: 10.1038/cddis.2012.211.", "ArticleIdList": ["10.1038/cddis.2012.211", "PMC3563998", "23370278"]}, {"Citation": "O\u2019Brien C.A., Kreso A., Jamieson C.H. Cancer stem cells and self-renewal. Clin. Cancer Res. 2010;16:3113\u20133120. doi: 10.1158/1078-0432.CCR-09-2824.", "ArticleIdList": ["10.1158/1078-0432.CCR-09-2824", "20530701"]}, {"Citation": "Luo M., Brooks M., Wicha M.S. Epithelial-mesenchymal plasticity of breast cancer stem cells: Implications for metastasis and therapeutic resistance. Curr. Pharm. Des. 2015;21:1301\u20131310. doi: 10.2174/1381612821666141211120604.", "ArticleIdList": ["10.2174/1381612821666141211120604", "PMC4498673", "25506895"]}, {"Citation": "Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer. 2010;102:639\u2013644. doi: 10.1038/sj.bjc.6605530.", "ArticleIdList": ["10.1038/sj.bjc.6605530", "PMC2837572", "20087353"]}, {"Citation": "Xia J., Guo S., Fang T., Feng D., Zhang X., Zhang Q., Liu J., Liu B., Li M., Zhu R. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem. Toxicol. 2014;66:7\u201313. doi: 10.1016/j.fct.2014.01.014.", "ArticleIdList": ["10.1016/j.fct.2014.01.014", "24444546"]}, {"Citation": "Guo Z., Guozhang H., Wang H., Li Z., Liu N. Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway. Biomed. Pharmacother. 2019;116:108524. doi: 10.1016/j.biopha.2018.12.136.", "ArticleIdList": ["10.1016/j.biopha.2018.12.136", "31108349"]}, {"Citation": "Yu F., Li J., Chen H., Fu J., Ray S., Huang S., Zheng H., Ai W. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 2011;30:2161\u20132172. doi: 10.1038/onc.2010.591.", "ArticleIdList": ["10.1038/onc.2010.591", "PMC3088782", "21242971"]}, {"Citation": "Zhang Y., Wang X. Targeting the Wnt/\u03b2-catenin signaling pathway in cancer. J. Hematol. Oncol. 2020;13:1\u201316. doi: 10.1186/s13045-020-00990-3.", "ArticleIdList": ["10.1186/s13045-020-00990-3", "PMC7716495", "33276800"]}, {"Citation": "Xiang H.-C., Lin L.-X., Hu X.-F., Zhu H., Li H.-P., Zhang R.-Y., Hu L., Liu W.-T., Zhao Y.-L., Shu Y. AMPK activation attenuates inflammatory pain through inhibiting NF-\u03baB activation and IL-1\u03b2 expression. J. Neuroinflammation. 2019;16:1\u201312. doi: 10.1186/s12974-019-1411-x.", "ArticleIdList": ["10.1186/s12974-019-1411-x", "PMC6373126", "30755236"]}, {"Citation": "Li W., Saud S.M., Young M.R., Chen G., Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget. 2015;6:7365\u20137378. doi: 10.18632/oncotarget.3629.", "ArticleIdList": ["10.18632/oncotarget.3629", "PMC4480686", "25812084"]}, {"Citation": "Dong L.-X., Sun L.-L., Zhang X., Pan L., Lian L.-J., Chen Z., Zhong D.-S. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells. Acta Pharmacol. Sin. 2013;34:314\u2013318. doi: 10.1038/aps.2012.143.", "ArticleIdList": ["10.1038/aps.2012.143", "PMC4011621", "23178462"]}, {"Citation": "Silva J., Yu X., Moradian R., Folk C., Spatz M.H., Kim P., Bhatti A.A., Davies D.L., Liang J. Dihydromyricetin protects the liver via changes in lipid metabolism and enhanced ethanol metabolism. Alcohol. Clin. Exp. Res. 2020;44:1046\u20131060. doi: 10.1111/acer.14326.", "ArticleIdList": ["10.1111/acer.14326", "PMC7211127", "32267550"]}, {"Citation": "Gao H., Liang D., Li C., Xu G., Jiang M., Li H., Yin J., Song Y. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Biomed. Pharmacother. 2020;124:109891. doi: 10.1016/j.biopha.2020.109891.", "ArticleIdList": ["10.1016/j.biopha.2020.109891", "31991384"]}, {"Citation": "Kim I., Kim M., Park M.K., Naik R., Park J.H., Kim B.-K., Choi Y., Chang K.Y., Won M., Ban H.S. The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1\u03b1 accumulation. Exp. Mol. Med. 2020;52:1845\u20131856. doi: 10.1038/s12276-020-00523-5.", "ArticleIdList": ["10.1038/s12276-020-00523-5", "PMC8080809", "33235318"]}, {"Citation": "Motolani A., Martin M., Sun M., Lu T. Phosphorylation of the Regulators, a Complex Facet of NF-\u03baB Signaling in Cancer. Biomolecules. 2021;11:15. doi: 10.3390/biom11010015.", "ArticleIdList": ["10.3390/biom11010015", "PMC7823564", "33375283"]}, {"Citation": "Chen L.-F., Greene W.C. Shaping the nuclear action of NF-\u03baB. Nat. Rev. Mol. Cell Biol. 2004;5:392\u2013401. doi: 10.1038/nrm1368.", "ArticleIdList": ["10.1038/nrm1368", "15122352"]}, {"Citation": "Capece D., Verzella D., Di Francesco B., Alesse E., Franzoso G., Zazzeroni F. NF-\u03baB and mitochondria cross paths in cancer: Mitochondrial metabolism and beyond. Semin. Cell Dev. Biol. 2020;98:118\u2013128. doi: 10.1016/j.semcdb.2019.05.021.", "ArticleIdList": ["10.1016/j.semcdb.2019.05.021", "31132468"]}, {"Citation": "Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., Saiki I. Tumor necrosis factor-\u03b1-induced IKK phosphorylation of NF-\u03baB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 2003;278:36916\u201336923. doi: 10.1074/jbc.M301598200.", "ArticleIdList": ["10.1074/jbc.M301598200", "12842894"]}, {"Citation": "Iqbal M., Verpoorte R., Korthout H.A.A.J., Mustafa N.R. Phytochemicals as a potential source for TNF-\u03b1 inhibitors. Phytochem. Rev. 2013;12:65\u201393. doi: 10.1007/s11101-012-9251-7.", "ArticleIdList": ["10.1007/s11101-012-9251-7"]}, {"Citation": "To N.B., Nguyen Y.T.-K., Moon J.Y., Ediriweera M.K., Cho S.K. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling. Nutrients. 2020;12:1663. doi: 10.3390/nu12061663.", "ArticleIdList": ["10.3390/nu12061663", "PMC7352840", "32503225"]}, {"Citation": "Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Hyun H.B., Moon J.Y., Cho S.K. Quercetin suppresses cyr61-mediated multidrug resistance in human gastric adenocarcinoma ags cells. Molecules. 2018;23:209. doi: 10.3390/molecules23020209.", "ArticleIdList": ["10.3390/molecules23020209", "PMC6017870", "29364834"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "18"}, {"Year": "2021", "Month": "7", "Day": "30"}, {"Year": "2021", "Month": "8", "Day": "6"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "1", "Minute": "5"}, {"Year": "2021", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "8", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["34451892", "PMC8400665", "10.3390/ph14080794", "ph14080794"]}}], "PubmedBookArticle": []}